Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 2Phase 1 2Phase 4 1Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 7Neutropenia 3Lymphoma, Non-Hodgkin 2Ovarian Neoplasms 1Malignant Solid Tumors 1Lymphoma 1Lung Neoplasms 1Fever 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 10Cisplatin 9Erlotinib Hydrochloride 8Carboplatin 7icotinib 5Gefitinib 5Docetaxel 5endostar protein 3Zoledronic Acid 3Radiotherapy 3Paclitaxel 3Gemcitabine 3Endostatins 3Afatinib 3tislelizumab 2pembrolizumab 2osimertinib 2lorlatinib 2flurbiprofen axetil 2dexamethasone 21-phosphate 2atezolizumab 2Vinorelbine 2Surgical Procedures, Operative 2Saline Solution 2Nivolumab 2Drug Therapy 2Dexamethasone 2Chemoradiotherapy 2trametinib 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Non-Small-Cell Lung × pegfilgrastim × Clear all
NCT00115206 2009-04-06

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Amgen

Phase 4 Completed
Thoracic

Carcinoma, Non-Small-Cell Lung, Fever, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡